HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs.

AbstractBACKGROUND:
During the vaccination campaigns, puppies younger than 3 months old are not targeted and remain unvaccinated for at least the first year of their lives. Almost half of the reported rabid dogs are 6 months or younger. Hence, we should recommend the vaccination against rabies of young puppies. Unfortunately, owing to the exposure of puppies to infections with either canine parvovirus (CPV) or distemper virus (CDV) after the intervention of the vaccinators, owners are reluctant to vaccinate puppies against rabies. Therefore, it is necessary to include the CPV and CDV valences in the vaccine against rabies. Multivalent DNA-based vaccination in dogs, including rabies and distemper valences, could help in raising vaccine coverage.
METHODS:
We have designed monovalent and multivalent DNA-based vaccine candidates for in vitro and in vivo assays. These plasmids encode to the rabies virus glycoprotein and/or the canine distemper virus hemagglutinin. The first strategy of multivalent DNA-based vaccination is by mixing plasmids encoding to a single antigen each. The second is by simply fusing the genes of the antigens together. The third is by adding the foot and mouth disease virus (FMDV) 2A oligopeptide gene into the antigen genes. The last strategy is by the design and use of a bicistronic plasmid with an "Internal Ribosome Entry Site" (IRES) domain.
RESULTS:
The monovalent construct against canine distemper was efficiently validated by inducing higher humoral immune responses compared to cell-culture-derived vaccine both in mice and dogs. All multivalent plasmids efficiently expressed both valences after in vitro transfection of BHK-21 cells. In BALB/c mice, the bicistronic IRES-dependant construct was the most efficient inducer of virus-neutralizing antibodies against both valences. It was able to induce better humoral immune responses compared to the administration of either cell-culture-derived vaccines or monovalent plasmids. The FMDV 2A was also efficient in the design of multivalent plasmids.
CONCLUSIONS:
In a single shot, the design of efficient multivalent plasmids will be very beneficial for DNA-based vaccination against numerous diseases.
AuthorsLeila Touihri, Sami Belhaj Ahmed, Yacine Chtourou, Rahma Daoud, Chokri Bahloul
JournalVirology journal (Virol J) Vol. 9 Pg. 319 (Dec 27 2012) ISSN: 1743-422X [Electronic] England
PMID23270301 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antigens, Viral
  • Hemagglutinins, Viral
  • RNA, Viral
  • Rabies Vaccines
  • Vaccines, DNA
  • Viral Proteins
Topics
  • Animals
  • Antibodies, Neutralizing (immunology)
  • Antibodies, Viral (immunology)
  • Antigens, Viral (immunology)
  • Chlorocebus aethiops
  • Distemper (genetics, immunology, prevention & control, virology)
  • Distemper Virus, Canine (immunology)
  • Dogs (immunology, virology)
  • Female
  • Foot-and-Mouth Disease Virus (genetics, metabolism)
  • Gene Fusion
  • Genes, Viral
  • Hemagglutinins, Viral (genetics, immunology, metabolism)
  • Immunity, Humoral
  • Mice
  • Mice, Inbred BALB C
  • Plasmids (metabolism)
  • RNA, Viral (genetics, metabolism)
  • Rabies (immunology, prevention & control, veterinary)
  • Rabies Vaccines (administration & dosage, genetics, immunology, metabolism)
  • Rabies virus (immunology)
  • Transfection
  • Vaccination (methods)
  • Vaccines, DNA (administration & dosage, immunology)
  • Vero Cells
  • Viral Proteins (genetics, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: